Alzheimer's disease

Horizons, Psychedelic Community's Largest and Longest-running Conference, to Hold its 15th Edition in New York City on October 12-16

Retrieved on: 
Wednesday, October 5, 2022

NEW YORK, Oct. 5, 2022 /PRNewswire/ -- Horizons, the world's longest-running annual event devoted to psychedelics, returns to the New York Academy of Medicine and The Great Hall at The Cooper Union from Wednesday, October 12 – Sunday, October 16, 2022.

Key Points: 
  • This year's program includes two days of classes for medical and care professionals, as well as four days of in-depth forums that explore the field of psychedelics.
  • Since 2007, Horizons has helped the public understand the world of psychedelics through live events and digital media.
  • Its flagship conference in New York City is the largest and longest-running annual gathering of the psychedelic community in the world.
  • Horizons is produced by Horizons PBC, a public benefit corporation based in New York City.

Business Leader Steve Cannon Named Honorary Chair for Inaugural Pathways to Leadership Class

Retrieved on: 
Wednesday, October 5, 2022

ATLANTA, Oct. 5, 2022 /PRNewswire/ -- The Atlanta Neuroscience Foundation announced today that Atlanta's business leader, Steve Cannon, will be the 2023 Pathways to Leadership Class Honorary Chairman participating with seventy-five of Atlanta's future corporate leaders.

Key Points: 
  • ATLANTA, Oct. 5, 2022 /PRNewswire/ -- The Atlanta Neuroscience Foundation announced today that Atlanta's business leader, Steve Cannon, will be the 2023 Pathways to Leadership Class Honorary Chairman participating with seventy-five of Atlanta's future corporate leaders.
  • "Cannon embodies what our Pathway to Leadership Class program represents," said Roy Rangel, Executive Director, Atlanta Neuroscience Foundation.
  • "His leadership within the corporate, sports, and entertainment arenas and incredible business acumen set a shining example for what all Pathways to Leadership honorees should strive to accomplish.
  • We are fortunate to have Steve Cannon as our Honorary Chair for our inaugural Class.

ANEW MEDICAL, INC. Acquires Five Drug Approvals with Manufacturing in Europe

Retrieved on: 
Tuesday, October 4, 2022

NEW YORK, Oct. 4, 2022 /PRNewswire/ -- ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK: LEAS) announced that it has acquired five market-approved anti-cancer drugs approved for sale in Germany.

Key Points: 
  • NEW YORK, Oct. 4, 2022 /PRNewswire/ -- ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK: LEAS) announced that it has acquired five market-approved anti-cancer drugs approved for sale in Germany.
  • The drugs are important in the treatment of many solid tumors in both childhood and adult cancers.
  • He also added that, "Having a European manufacturing source for each of the five MA's was also important to us."
  • The prices of our products are, therefore, affordable even in this era of significantly increased energy prices in Europe.

Praetego Inc Awarded $2.5M by the NIH National Institute of Aging to Advance Novel Drug Candidate Against Alzheimer's Disease

Retrieved on: 
Tuesday, October 4, 2022

The Phase 2 award advances Praetego's lead candidate, PTG-630, against Alzheimer's disease (AD).

Key Points: 
  • The Phase 2 award advances Praetego's lead candidate, PTG-630, against Alzheimer's disease (AD).
  • The award allows Praetego to accelerate development of PTG-630 towards preventing the progression of Alzheimer's Disease (AD).
  • Praetego's grant follows promising findings obtained during a supplemental award from the NIA targeted at novel AD therapeutics.
  • This ongoing support from the NIH has enabled Praetego to progress its novel scientific approach to disorders of aging and neurodegeneration, and specifically AD."

Lumeris Appoints Ben Grabski as Chief Financial Officer

Retrieved on: 
Tuesday, October 4, 2022

ST. LOUIS, Oct. 4, 2022 /PRNewswire/ -- Lumeris , a leading provider of the technology, insurance capabilities and expertise needed to support value-based care models, announced today the appointment of Ben Grabski as Chief Financial Officer.

Key Points: 
  • ST. LOUIS, Oct. 4, 2022 /PRNewswire/ -- Lumeris , a leading provider of the technology, insurance capabilities and expertise needed to support value-based care models, announced today the appointment of Ben Grabski as Chief Financial Officer.
  • "Ben is an extraordinary leader with an impressive track record of developing financial strategies to helpbusinesses drive profitability through organic growth and new market expansions," said Mike Long, CEO of Lumeris.
  • Ben is a proven business leader and finance executive with more than a decade of experience leading and scaling managed care organizations.
  • Lumeris is proud to offer 5-star health plans that consistently deliver better clinical and financial outcomes for Medicare, Medicaid, Commercial, and Individual populations.

Seth Rogen and Lauren Miller Rogen's Non-Profit Hilarity for Charity Raises $877,000 For Alzheimer's At 10th Birthday Extravaganza With Star-Studded Line Up

Retrieved on: 
Tuesday, October 4, 2022

LOS ANGELES, Oct. 4, 2022 /PRNewswire/ -- Seth Rogen and Lauren Miller Rogen's Hilarity for Charity (HFC), a national non-profit organization on a mission to care for families impacted by Alzheimer's disease, activate the next generation of Alzheimer's advocates, and be a leader in brain health education, marked a milestone of 10 years (#HBDHFC) and raised over $877,000 to support the mission. The event took place at Rolling Greens on Mateo in Downtown Los Angeles and featured star-studded performances, including an acoustic set from John Mayer, carnival games, a celebrity-hosted live auction, food trucks, drinks, and laughs.

Key Points: 
  • "10 years is truly a milestone, and we celebrated the only way we knew how, with a giant birthday bash and lots of laughs!
  • We are so thankful to our community of supporters who have enabled HFC to grow into the innovative and impactful organization we are today.
  • Our board, donors, sponsors, friends, and supporters: we feel so hopeful with them on this mission with us.
  • Care for caregivers and brain health education remain our focus and we intend to invest and advance for as long as it takes to end Alzheimer's and its negative impact on families," said Seth Rogen & Lauren Miller Rogen.

Xosomix Awarded NIH Phase I SBIR Grant to Develop Diagnostic Biomarker for Endometriosis

Retrieved on: 
Tuesday, October 4, 2022

This grant will enable Xosomix to develop an early diagnostic biomarker for endometriosis.

Key Points: 
  • This grant will enable Xosomix to develop an early diagnostic biomarker for endometriosis.
  • Xosomix receives SBIR from NICHD to develop non-invasive biomarker that avoids surgery, the only FDA approved diagnosis
    Approximately 10% of reproductive age women, more than 4 million in United States alone, are affected by endometriosis.
  • This is an underestimate as invasive surgery is the only FDA approved diagnosis of endometriosis.
  • Xosomix has a proprietary platform technology that can tap into all the signals in exosomes on an individual basis at discovery phase.

MSCA Expansion in Care Promotes New Name Change to Atlanta Neuroscience Institute

Retrieved on: 
Tuesday, October 4, 2022

ATLANTA, Oct. 4, 2022 /PRNewswire/ -- The Multiple Sclerosis Center Of Atlanta is proud to share that they are now Atlanta Neuroscience Institute.

Key Points: 
  • ATLANTA, Oct. 4, 2022 /PRNewswire/ -- The Multiple Sclerosis Center Of Atlanta is proud to share that they are now Atlanta Neuroscience Institute.
  • This new name clearly defines the vast area of neurological care support offered through the Atlanta Neuroscience Institute.
  • With this new name and expanded mission, Atlanta Neuroscience Institute hopes to further its reach to those who greatly need specialized neurological care.
  • Additionally, Atlanta Neuroscience Institute remains committed to carrying the torch of MSCA and broadening the future for more patients diagnosed with neurological diseases.

BioVie Issues Letter to Shareholders

Retrieved on: 
Tuesday, October 4, 2022

Thus, Ive prepared this shareholders letter to explain our excitement and to provide updates on our other programs.

Key Points: 
  • Thus, Ive prepared this shareholders letter to explain our excitement and to provide updates on our other programs.
  • BioVie has always held and the data from thousands of publications suggest that Alzheimers disease pathology is driven by multiple factors.
  • BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing innovative therapies to overcome unmet medical needs in chronic debilitating conditions.
  • Although BioVie Inc. believes such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained.

Allegheny Health Network Awarded Grant from Henry L. Hillman Foundation to Support New Program for Those Living with Dementia and Their Caregivers

Retrieved on: 
Monday, October 3, 2022

PITTSBURGH, October 03, 2022 /PRNewswire-PRWeb/ -- Allegheny Health Network (AHN) has been named one of four recipients of the Henry L. Hillman Foundation "Healthy Aging Challenge" grant. This $500,000 award will support the establishment of a comprehensive program for persons living with dementia and their caregivers, known as the 'AHN Aging Brain Care Program and Dementia Super Network.' The program will leverage an evidence-based model which integrates specialized staff into primary care teams and addresses the stresses and hardships commonly held among family caregivers.

Key Points: 
  • PITTSBURGH, October 03, 2022 /PRNewswire-PRWeb/ -- Allegheny Health Network ( AHN ) has been named one of four recipients of the Henry L. Hillman Foundation " Healthy Aging Challenge " grant.
  • This $500,000 award will support the establishment of a comprehensive program for persons living with dementia and their caregivers, known as the 'AHN Aging Brain Care Program and Dementia Super Network.'
  • Both persons living with dementia and their caregivers are significantly impacted by the disease as individuals become unable to care for and make decisions for themselves.
  • "The rise in the number of people living with dementia means that caregivers need specialized training and support more than ever," said Lauri Fink, senior program officer of Henry L. Hillman Foundation.